Five-year outcomes after coronary stenting versus bypass surgery for the treatment of multivessel disease : The final analysis of the Arterial Revascularization Therapies Study (ARTS) randomized trialSERRUYS, Patrick W; ONG, Andrew T. L; BACKX, Bianca et al.Journal of the American College of Cardiology. 2005, Vol 46, Num 4, pp 575-581, issn 0735-1097, 7 p.Article

Effects of sumatriptan and eletriptan on diseased epicardial coronary arteriesNEWMAN, Christopher M. H; STARKEY, Ian; BULLER, Nigel et al.European journal of clinical pharmacology. 2005, Vol 61, Num 10, pp 733-742, issn 0031-6970, 10 p.Article

Comparison of coronary-artery bypass surgery and stenting for the treatment of multivessel diseaseSERRUYS, Patrick W; UNGER, Felix; MOREL, Marie-Angele M et al.The New England journal of medicine. 2001, Vol 344, Num 15, pp 1117-1124, issn 0028-4793Article

Five year clinical effect of coronary stenting and coronary artery bypass grafting in renal insufficient patients with multivessel coronary artery disease : insights from ARTS trialAOKI, Jiro; ONG, Andrew T. L; LINDEBOOM, Wietze et al.European heart journal. 2005, Vol 26, Num 15, pp 1488-1493, issn 0195-668X, 6 p.Article

A pharmacoeconomic evaluation of the Myocardial ischaemia reduction with Aggressive Cholesterol Lowering (MIRACL) study in the United KingdomBULLER, Nigel; GILLEN, David; CASCIANO, Roman et al.PharmacoEconomics (Auckland). 2003, Vol 21, pp 25-32, issn 1170-7690, 8 p., SUP1Article

The elective use of the seven-cell NIR stent in coronary arteries < 2.75 mm in diameter : Clinical and angiographic results at 6-month follow-upECCLESHALL, Simon C; JONES, Heather; LICHFIELD, Maureen et al.Catheterization and cardiovascular interventions. 2001, Vol 54, Num 2, pp 174-179, issn 1522-1946Article